User: Guest  Login
Title:

Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.

Document type:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
Author(s):
Wienecke, R; Fackler, I; Linsenmaier, U; Mayer, K; Licht, T; Kretzler, M
Abstract:
A 19-year old patient with tuberous sclerosis presented with a renal angiomyolipoma. Because animal trials of tuberous sclerosis showed an effect of rapamycin on renal tumors, our patient was administered rapamycin for 6 months. During this time, the renal angiomyolipoma shrank significantly, regrew during an 8-month period, and decreased in size again after readministration of rapamycin.
Journal title abbreviation:
Am J Kidney Dis
Year:
2006
Journal volume:
48
Journal issue:
3
Pages contribution:
e27-9
Language:
eng
Fulltext / DOI:
doi:10.1053/j.ajkd.2006.05.018
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/16931204
Print-ISSN:
0272-6386
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX